Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Antiviral Research|October 11, 2021
SARS-CoV-2 monoclonal antibodies with therapeutic potential: Broad neutralizing activity and No evidence of antibody-dependent enhancementYing-Ting Wang, Robert D Allen, Kenneth Kim, et al.
Frontiers in Cellular and Infection Microbiology|December 15, 2016
Clinical and Genomic Analysis of Liver Abscess-Causing <i>Klebsiella pneumoniae</i> Identifies New Liver Abscess-Associated Virulence GenesMeiping Ye, Jianfei Tu, Jianping Jiang, et al.
Vaccines|May 25, 2024
Longitudinal Analysis of Humoral and Cellular Immune Response up to 6 Months after SARS-CoV-2 BA.5/BF.7/XBB Breakthrough Infection and BA.5/BF.7-XBB ReinfectionXun Wang, Meng Zhang, Kaifeng Wei, et al.
Expert Opinion on Biological Therapy|December 11, 2023
Discovery of novel cMET-targeting antibody Fab drug conjugates as potential treatment for solid tumors with highly expressed cMETReyna Kv Lim, Matthew Buschman, Alisher Khasanov, et al.
Emerging Microbes & Infections|December 6, 2023
Risk of reinfection and severity with the predominant BA.5 Omicron subvariant China, from December 2022 to January 2023Jianpeng Cai, Haocheng Zhang, Kun Zhu, et al.
Advanced Materials (Deerfield Beach, Fla.)|February 10, 2025
A Printed Microscopic Universal Gradient Interface for Super Stretchable Strain-Insensitive BioelectronicsKaidong Song, Jingyuan Zhou, Chen Wei, et al.
Emerging Microbes & Infections|December 22, 2021
Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boostJingwen Ai, Haocheng Zhang, Yi Zhang, et al.
BMC Infectious Diseases|January 9, 2022
Optimal encephalitis/meningitis roadmap via precise diagnosis and treatment (IMPROVE): a study protocol for a randomized controlled trialYi Zhang, Haocheng Zhang, Bo Deng, et al.
Nature|May 10, 2023
High-throughput printing of combinatorial materials from aerosolsMinxiang Zeng, Yipu Du, Qiang Jiang, et al.
Cell Host & Microbe|November 29, 2023
Enhanced neutralization of SARS-CoV-2 variant BA.2.86 and XBB sub-lineages by a tetravalent COVID-19 vaccine boosterXun Wang, Shujun Jiang, Wentai Ma, et al.
Pageof 10